Conditions: Endometriosis
Keywords: Endometriosis Pelvic pain Oral progesterone blocker
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 18
Healthy volunteers: no

Brief summary:
ZPE-201 Extension of treatment

Detailed description:
This is an extension of the phase II, three-arm, parallel design, dose-ranging, placebo-controlled, randomized, double-blind, multicenter study in which placebo or one (1) of two (2) dose levels of Proellex® was administered once-daily for four (4) months.

Arms:
arm 1: 25 mg Proellex®

Interventions: intervention 1: Proellex®
Intervention descriptions: intervention 1: one (1) 25 mg capsule daily

Protocol document: